West Pharmaceutical Services PE Ratio 2010-2023 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of May 10, 2024 is 47.54.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-10 364.19 46.22
2023-12-31 351.75 $7.88 44.64
2023-09-30 374.82 $7.41 50.58
2023-06-30 381.88 $6.86 55.67
2023-03-31 345.75 $7.28 47.49
2022-12-31 234.69 $7.72 30.40
2022-09-30 245.18 $8.29 29.58
2022-06-30 301.08 $9.01 33.42
2022-03-31 408.77 $9.00 45.42
2021-12-31 466.56 $8.70 53.63
2021-09-30 422.14 $8.06 52.38
2021-06-30 356.91 $6.84 52.18
2021-03-31 279.91 $5.58 50.16
2020-12-31 281.27 $4.58 61.41
2020-09-30 272.76 $4.13 66.04
2020-06-30 225.27 $3.79 59.44
2020-03-31 150.83 $3.46 43.59
2019-12-31 148.77 $3.20 46.49
2019-09-30 140.19 $3.05 45.96
2019-06-30 123.56 $3.03 40.78
2019-03-31 108.66 $2.90 37.47
2018-12-31 96.52 $2.75 35.10
2018-09-30 121.41 $2.06 58.94
2018-06-30 97.49 $2.00 48.75
2018-03-31 86.56 $1.76 49.18
2017-12-31 96.60 $1.99 48.54
2017-09-30 94.10 $2.51 37.49
2017-06-30 92.27 $2.34 39.43
2017-03-31 79.54 $2.43 32.73
2016-12-31 82.55 $1.92 43.00
2016-09-30 72.37 $1.85 39.12
2016-06-30 73.60 $1.37 53.72
2016-03-31 67.12 $1.15 58.37
2015-12-31 58.19 $1.30 44.76
2015-09-30 52.18 $1.28 40.76
2015-06-30 55.90 $1.69 33.08
2015-03-31 57.83 $1.83 31.60
2014-12-31 51.03 $1.76 28.99
2014-09-30 42.80 $1.66 25.78
2014-06-30 40.23 $1.60 25.14
2014-03-31 41.92 $1.51 27.76
2013-12-31 46.59 $1.58 29.49
2013-09-30 39.00 $1.55 25.16
2013-06-30 33.21 $1.40 23.80
2013-03-31 30.60 $1.19 25.71
2012-12-31 25.71 $1.15 22.45
2012-09-30 24.83 $1.12 22.27
2012-06-30 23.54 $1.15 20.56
2012-03-31 19.74 $1.21 16.38
2011-12-31 17.53 $1.08 16.23
2011-09-30 17.06 $0.90 18.95
2011-06-30 20.04 $0.91 22.03
2011-03-31 20.43 $0.94 21.85
2010-12-31 18.72 $0.94 19.92
2010-09-30 15.52 $1.15 13.55
2010-06-30 16.43 $1.14 14.41
2010-03-31 18.82 $1.12 16.88
2009-12-31 17.51 $1.06 16.52
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.529B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.780B 20.42
Becton Dickinson (BDX) United States $68.110B 19.27
Cardinal Health (CAH) United States $24.242B 13.86
Align Technology (ALGN) United States $20.454B 39.49
Cooper (COO) United States $18.834B 28.50
Labcorp (LH) United States $17.507B 15.07
Henry Schein (HSIC) United States $9.419B 16.70
DENTSPLY SIRONA (XRAY) United States $5.791B 14.99
Merit Medical Systems (MMSI) United States $4.697B 25.74
Patterson (PDCO) United States $2.267B 10.86
CONMED (CNMD) United States $2.192B 19.88
STAAR Surgical (STAA) United States $2.081B 79.91
Atrion (ATRI) United States $0.784B 41.86
Lifevantage (LFVN) United States $0.085B 10.98
Pro-Dex (PDEX) United States $0.064B 32.09
Biolase (BIOL) United States $0.006B 0.00